RE:RE:RE:RE:1 Patient enrolled per month..Hmmmmmmm - nobody can do a precise calculation unless you're on the inside. Management knows and the BOD knows and Baxter/KidneyCo know as they are all privy to the redacted Baxter agreement together with the results of the Tigris trial and numerous other pieces of information on the inside. They even know what happened that led to the loss of 70% of Dialco. But they're not sharing.
Each of us have our own ideas of value. With the sharks swimming around the BB you'd have to be brave and/or stupid to put forth a detailed calculation. As it would be a free for all by some intelligent posters and all the kindergarden flunkees that are on here.
I see a value of $10 a share but I think we get less than that ultimately. Don't ask for details as none will be provided. Agree or disagree it matters not to me. But I'll ask you what do you think the value is and what do you think we ultimately get?